Calledo, Asahel .
HRN: 22-61-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2024
CEFUROXIME 750MG (VIAL)
04/27/2024
05/04/2024
IV
285mg
Q 8 Hours
T/C AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes